Vancouver, BC's thriving life sciences sector is set to receive a significant enhancement thanks to federal support. The government is allocating $140 million to four projects in British Columbia as part of establishing "Canada’s Immuno-Engineering and Biomanufacturing Hub." This funding is a segment of a broader $574 million initiative aimed at bolstering 19 projects across five research hubs nationwide under Canada’s #biomanufacturing and #lifesciences strategy. This investment will empower local medical researchers to transition their discoveries into startup ventures, further invigorating the region's biotechnological advancements. https://lnkd.in/g-ps4Gbf
SRED Unlimited’s Post
More Relevant Posts
-
Ontario’s #lifesciences sector is world-renowned, with competitive advantages in R&D and pharmaceuticals to the manufacturing of clinical devices and biotechnology innovations. That’s why through Phase 2 of “Taking Life Sciences to the Next Level”, we are investing $146M to continue growing the sector, by: ☑️ Boosting research capacity ☑️ Increasing access to lab space ☑️ Speeding up health trials ☑️ Launching modernized procurement processes and ☑️ Establishing new funds
Ontario launches second phase of life sciences strategy to bolster research and funding
https://betakit.com
To view or add a comment, sign in
-
I am incredibly proud to announce that we have been awarded a £1.6M project from Innovate UK’s Biomedical Catalyst 2023 Round 2: Industry-led R&D 🙌 This application took a tremendous amount of effort, including working well into the early hours of many mornings to perfect the initial submission and cancelling leave over Christmas to prepare for the interview stage. Innovate UK grants (rightly!) require significant work; the application is scrutinised by five experienced assessors from various areas across Life Sciences. The next-stage interview is then attended by up to ten other people, with our panel including professionals from the NHS, academia, and CDMOs, among others. With a pot of £17.8M, and average project cost at £415,191, only 30 of the 358 applications could be funded 💰 . It is therefore truly gratifying to have so many experts agree that the cause we are developing solutions for is important and worthy of this substantial investment ✊ We do not take this funding lightly and will work tirelessly to ensure the success of our exciting project. Time to get cracking! https://lnkd.in/ev58aTt8 #biomedicalcatalyst #healthcare #infantmicrobiome #microbiome #grantfunding #grants #investment #innovateuk #biotech
BoobyBiome Secures £1.6M Innovate UK Biomedical Catalyst Grant for Groundbreaking Synbiotic Research
boobybiome.com
To view or add a comment, sign in
-
An article highlighting Providence Research’s contributions to British Columbia’s growing ecosystem of biotechnology research is featured in the latest edition of BIOTECanada's Insights magazine, which is dedicated to showcasing the best of Canadian biotechnology. The spring issue of Insights showcases exclusive interviews with industry leaders, federal government perspectives, and ground-breaking research highlighting the dynamic landscape and future potential of Canada’s biotech sector. The article from Dr. Darryl Knight, President, Providence Research, covers the new Phase 1 Clinical Trials Unit at Mount Saint Joseph Hospital, and the consolidated Phase 1-3 Clinical Trials Unit that will be included at the Clinical Support and Research Centre at the new St. Paul’s Hospital. These state-of-the-art research facilities will serve a growing demand for non-cancer Phase 1 clinical trials in B.C., and foster collaboration between researchers, clinicians and industry experts to advance medical discovery. Read it here: https://lnkd.in/gr9KEd_C #research #healthcare #healthresearch #clinicaltrials #innovation #biotech #biotechnology
To view or add a comment, sign in
-
This Globe and Mail article, by Sean Silcoff, is a who's who of the B.C. life sciences sector and a great overview of what's happening in the province now. Here are some highlights: “I want to build a $100-billion company, but it has to be here, it can be here, and it will be here,” says Tamer Mohamed, chief executive officer of Aspect Biosystems, which occupies QLT’s former home and whose cutting-edge approach to curing diabetes landed it on Fast Company’s 2023 “Next Big Things in Tech” list. “To get there we have to be a bit un-Canadian about it.” Aspect is a CCRM portfolio company. Vancouver is already Canada’s fastest-growing biotech centre, with 8,000 jobs added over the past 10 years, up to nearly 20,000, while the number of businesses in B.C. grew by 26.5 per cent from 2018 to 2021. “Vancouver probably has the critical mass of talent, companies, capital and technology to put it in the top 10 globally" of biotech centres despite lacking Toronto and Montreal’s Big Pharma branch locations, says Brian Bloom, CEO of Toronto life sciences underwriter Bloom Burton & Co. cc: Peter Zandstra, Abi Coman-Walker, STEMCELL Technologies, Jerel Davis https://lnkd.in/gnZYptpE
B.C. biotech boom: Vancouver looks to join the global big leagues of modern medicine
theglobeandmail.com
To view or add a comment, sign in
-
Post 3 of 4 The annual BIONATION Summit brings industry leaders together with federal policymakers to share views and perspectives on the state of Canada’s biotech sector and identify ways to work together to attract investment and accelerate company growth and commercial success. 🗓 42 days to go until BIONATION on September 24-25 in Ottawa, where we'll explore the future opportunities for the sector through four key discussion themes. Today, we're excited to highlight our third program theme: People Powering the Ecosystem: Curiosity, discovery, ingenuity, and expertise are the trademarks of the highly skilled national network of people who are driving the momentous growth of the life science ecosystem in Canada. Known for the calibre of our research and a highly skilled workforce, Canada has established its credentials as a place where biotechnology innovation thrives. The current momentum of the sector throughout Canada and sheer volume of growth presents an unprecedented opportunity for employment growth, career development and leadership. Meeting this moment with the talent of today and inspiring the talent needed for tomorrow, is an inspiring and motivating opportunity the sector is working to address. Don't miss out on this unique opportunity to engage with industry leaders and shape the future of biotechnology in Canada. To view additional program details visit: https://lnkd.in/dUeJCWJC #BIONATION2024 #biotech #biotechnology #innovation #events #cdnpoli #canada #policy #investment #research #BIONATION AbbVie, Novartis, CASTL - Canadian Alliance for Skills and Training in Life Sciences BioTalent, Fonds de solidarité FTQ, Stem Cell Network, adMare BioInnovations, AstraZeneca
To view or add a comment, sign in
-
How may I help you grow in the biotechnology and biopharmaceutical sectors? I have a network that can assist in your growth journey, and I'm committed to supporting you in any way I can. The biotechnology and biopharmaceutical sectors in North Carolina are rapidly expanding, offering a plethora of opportunities to explore. The state's dedication to innovation and health is evident in this growth, showcasing the abundance of prospects available in our region. North Carolina stands out as a national leader in biotech, with numerous companies expanding their presence and investing in cutting-edge technologies. Learn more about North Carolina's booming biotech sector here: https://lnkd.in/e6dr3Fnq #Biotechnology #Biopharmaceutical #NorthCarolina #Innovation #GrowthOpportunities
Accelerating equitable growth in North Carolina’s life sciences cluster | Brookings
https://www.brookings.edu
To view or add a comment, sign in
-
Post 4 of 4 Only 35 days remain until BIONATION in Ottawa on September 24-25! During the event, we'll dive into future opportunities for the sector through four major discussion themes. Today, we’re excited to spotlight our fourth program theme: Scaling & Anchoring Canadian Excellence: With record setting investments and world leading Canadian scientific discoveries, Canada has set the stage for historical growth in life science companies throughout the country. The ambition is clear-realize Canadian founded and developed companies as global commercialized successes anchored in Canada. Recent momentum of the sector has catapulted a number of Canadian companies to the forefront of what can serve to be the emergence of dozens of potential “anchors” for the ecosystem throughout Canada. Capitalizing on this momentum requires timely, systematic policy to build regulatory performance and attract investment. The fundamentals are in place–let’s get this done. Don't miss out on this unique opportunity to engage with industry leaders and shape the future of biotechnology in Canada. To view additional program details visit: https://lnkd.in/dUeJCWJC #BIONATION2024 #biotech #biotechnology #innovation #events #cdnpoli #canada #policy #investment #research #BIONATION AbbVie, Novartis, CASTL - Canadian Alliance for Skills and Training in Life Sciences BioTalent Canada, Fonds de solidarité FTQ, Stem Cell Network, adMare BioInnovations, AstraZeneca
To view or add a comment, sign in
-
Still buzzin' about this news: Ontario has launched phase 2 of Life Sciences strategy! Meaning the province is investing an additional $146M to establish Ontario as a global biomanufacturing and life sciences hub. 4 focus areas of government investment include: - Up to $46M for the Ontario Biosciences Research Infrastructure Fund, to help boost research capacity at postsecondary institutions and affiliated research hospitals. - $15M for a new wet labs program to reduce the time and barriers companies face when looking to access lab spaces, and $5M for Clinical Trials Ontario's QuickSTART Initiative to speed up health trials. - $24M for a new Life Sciences Scale-Up Fund (LSSUF) to help Ontario companies expand production capacity and prepare them for new procurement opportunities in Ontario and beyond. The LSSUF will act in tandem with the $12M Health Technology Accelerator Fund (HTAF), announced in the 2024 Budget, providing opportunities for innovators, including Ontario companies, to partner with local health care service providers. - An additional $40M from the Venture Ontario Fund to invest in venture capital funds that will help Ontario-based life sciences companies and biomanufacturers innovate and grow. Hope this leads more Life Sci companies to grow, grow, grow in Ontario! #lifesciences #lifesciencesontario #lifesciencescanada #biotechnologycanada
Ontario Launches Next Phase of Life Sciences Strategy | Ontario Newsroom
news.ontario.ca
To view or add a comment, sign in
-
✴ BGN's Bio Team shines at the Biomed Israel 2024 We had a strong presence at the recent Biomed Israel 2024 conference in Tel Aviv. Our bio team Galit Mazooz - Perlmuter 🎗 Ph.D Hagit Alon, (PhD) Micha Oestereich showcased cutting-edge technologies from Ben-Gurion University researchers and engaged in a whirlwind of activities. Our team had personal discussions with leading biotech and pharmaceutical companies, entrepreneurs who are seeking to adopt new technologies, venture capitalists, and industry colleagues. Conversations focused on potential collaborations, partnerships, and pathways to commercialize BGN's innovative biomedical technologies. The team also connected with existing partners like Magneto Thrombectomy Solutions, and OncoRedox Ltd., companies licensed by BGN .🤝 The goal was to drive innovation by facilitating the integration of Ben-Gurion's groundbreaking research into products and therapies. Through these meetings and networking opportunities, we took strides toward assimilating the university's biomedical breakthroughs into the broader life sciences industry. All in all, the Biomed Israel 2024 was a great opportunity to explore promising opportunities for Ben-Gurion's biomedical technologies. Josh Peleg #Biomed2024 #Biopharma #bioinnovation #Biotech
To view or add a comment, sign in
-
Looking forward to participating with my talk on AI in medical imaging.
Ohio Eminent Scholar, Professor of Pharmacology, Physiology & Neurobiology - University of Cincinnati College of Medicine | Cardiac and Systemic Metabolic Biology | Heart Failure | Cell signaling | Gene expression
To all undergraduate and graduate students (incl. clinical trainees) in Greece that I am connected with: Do not miss the opportunity to attend the BIO3 conference (https://lnkd.in/dDFzwEjz) taking place at Technopolis-Athens on September 1-5, 2024. Thanks to a generous donation of the John S. Latsis Public Benefit Foundation, a 95% discount is offered to the first 200 students that will register (student fee: €25). Highlights of Bio3-2024 Biomedicine, Bioinformatics & Biotechnology Forum 100 World-Class Speakers Experts from 13 countries 38 biotech and pharmaceutical companies from around the world 10 investment firms and numerous angel investors. 25 Innovation Showcase Sessions. 9 Collaborative Panels. Networking Opportunities. Nikos Kyrpides, Georgios Pavlopoulos, Georgia Kokaraki PhD, PMP, Michalis Hadjithomas, gregory amoutzias, Maria-Cristina (Maritina) Grelloni
To view or add a comment, sign in
325 followers